Loading stock data…
Globe Life Inc. (GL)
$170.68-3.59 (-2.06%)
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Globe Life Inc. in the Financial Services sector is trading at $170.68 with a market capitalization of $14.1B. Wall Street consensus targets $193.91 (11 analysts), implying a +13.6% move over the next 12 months. The stock is currently 11% below its 52-week high of $191.55, remaining 11.0% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +13.6% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $1.56B↑ | $1.52B↑ | $1.51B↑ | $1.48B |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | $365.84M↓ | $367.05M↓ | $513.24M↑ | $348.18M |
| Net Income | — | $270.53M↑ | $266.08M↓ | $387.84M↑ | $252.75M |
Peer Comparison
JPMBACGS
Fundamentals
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$14.05B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
12.04
Beta
Defensive asset. Lower volatility than the S&P 500.
0.47
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.70%
ROE
Elite ROE. Management converts capital into profit efficiently.
15.19%
Volume
Today's trading volume
370,883
Recent News
3 Insurance Stocks We Keep Off Our Radar
Insurance providers use their expertise in risk assessment to help protect assets while offering consumers peace of mind through comprehensive coverage options. Market leaders have certainly capitalized on strong underwriting results and rising investment income to boost profitability, helping fuel a 12.3% gain for the industry over the past six months. This performance has closely followed the S&P 500.
Want Double-Digit Gains From Insurance Stocks? Morgan Stanley Suggests 2 Names to Consider
Insurance has spent the past 20 years doing many of the things investors usually appreciate, without getting much credit for them. The industry has returned cash through dividends and buybacks, produced relatively dependable earnings, and attracted famous long-term investors such as Warren Buffett. What it has not done particularly well is turn steady business growth into equally strong profit growth. McKinsey estimates that global insurance premiums have grown at an annual rate of about 4.9% si
3 Reasons to Avoid GL and 1 Stock to Buy Instead
Globe Life’s 20.2% return over the past six months has outpaced the S&P 500 by 9.3%, and its stock price has climbed to $171.06 per share. This performance may have investors wondering how to approach the situation.
Globe Life's Health Insurance Growth Powers Earnings Momentum
GL's health business gains momentum from strong premium growth, rate increases and expanding distribution, though medical inflation poses risks.
Globe Life (GL) Down 0.3% Since Last Earnings Report: Can It Rebound?
Globe Life (GL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.